La chaîne d'options affiche les données clés des options sur actions de Propanc Biopharma à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour Propanc Biopharma..

Propanc Biopharma (NASDAQ:PPCB) Stock, Chaîne d'Options

Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.

Propanc Biopharma Inc

Press Releases

Propanc Biopharma Provides Shareholder Update

News

Financing

Propanc Biopharma Announces Plan to Acquire $100 Million of Ethereum

Stopping Cancer Before It Spreads: The EMT Revolution in Oncology

Health Care

Legal

Propanc Biopharma Receives Certificate of Grant for "Proenzyme Composition" Patent from US Patent & Trademark Office

Crypto and Cancer: How Biotech's New Strategy Is Turning Heads

Propanc Reports End of Fiscal Year Highlights and Outlines Therapeutic Development & $100M+ Digital Asset Treasury Strategy

CORRECTION: Propanc Biopharma Announces Strategic Financing Agreement of up to $100 Million with Hexstone Capital

Propanc Biopharma, Inc. Pursues Strategic Acquisition Plan Targeting Digital Asset Treasury (DAT) Companies Trading Below Market Cap to Net Asset Value (MNAV)

From Lab Bench to Blockchain: How Biotech is Reinventing Funding

$BTC

$ETH

BMNR

BTCS

CSE:QNTM

ETHZ

HOTH

MSTR

PPCB

QNTM

RHHBY

Abpro Hldgs

AEON Biopharma, Inc. Class A Common Stock

AEON Biopharma

Allarity Therapeutics, Inc. - Common stock

Allarity Therapeutics

Aptevo Therapeutics

BioCardia

BriaCell Therapeutics Corp. - Common Shares

BriaCell Therapeutics

BioVie

BioLineRx Ltd. - American Depositary Shares

BioLine Rx

BioRestorative Therapies, Inc. - Common Stock

BioRestorative Therapies

CASI Pharmaceuticals, Inc. - Ordinary Shares

CASI Pharmaceuticals

Curis

Dogwood Therapeutics, Inc. - Common Stock

Dogwood Therapeutics

Edesa Biotech

enGene Holdings

Ernexa Therapeutics

FibroBiologics

Geovax Labs

Kairos Pharma

Kazia Therapeutics Limited - American Depositary Shares

Kazia Therapeutics

Longeveron

Lisata Therapeutics

Marker Therapeutics

OSR Holdings

Propanc Biopharma

Soligenix

Synlogic

PROPANC BIOPHARMA INC by Propanc Biopharma, Inc.

Comments

Propanc Biopharma

Propanc Biopharma (PPCB) Options

No option chain data available. Please try again later

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL